Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168–181.
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT, De Simone G. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev. 2012;112(8):4421–4468.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Winum JY, (eds.). Hoboken drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. NJ: Wiley; 2009.
   Google Scholar
• Xu Y, Feng L, Jeffrey PD, Shi Y, Morel FM. Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms. Nature. 2008;452(7183):56–61.
   PubMed Web of Science ®Google Scholar
• Lane TW, Saito MA, George GN, Pickering IJ, Prince RC, Morel FM. Biochemistry: a cadmium enzyme from a marine diatom. Nature. 2005;435(7038):42.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat. 2018;28(10):709–712.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Fisher GM, Andrews KT, Poulsen SA, Capasso C, Supuran CT. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum–the η-carbonic anhydrases. Bioorg Med Chem Lett. 2014;24(18):4389–4396.
   PubMed Web of Science ®Google Scholar
• De Luca V, Giovannuzzi S, Supuran CT, Capasso C. May sulfonamide inhibitors of carbonic anhydrases from mammaliicoccus sciuri prevent antimicrobial resistance due to gene transfer to other harmful staphylococci? IJMS. 2022;23(22):13827.
   Google Scholar
• Del Prete S, Bua S, Supuran CT, Capasso C. Escherichia coliγ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors. J Enzyme Inhib Med Chem. 2020;35(1):1545–1554.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat. 2018;28(10):745–754.
   PubMed Web of Science ®Google Scholar
• Kikutani S, Nakajima K, Nagasato C, Tsuji Y, Miyatake A, Matsuda Y. Thylakoid luminal θ-carbonic anhydrase critical for growth and photosynthesis in the marine diatom Phaeodactylum tricornutum. Proc Natl Acad Sci U S A. 2016;113(35):9828–9833.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem. 2015;30(2):325–332.
   PubMed Web of Science ®Google Scholar
• Jensen EL, Clement R, Kosta A, Maberly SC, Gontero B. A new widespread subclass of carbonic anhydrase in marine phytoplankton. Isme J. 2019;13(8):2094–2106.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Nocentini A, Supuran CT, Capasso C. Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem. 2020;35(1):1060–1068.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007;15(13):4336–4350.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Latest advances in specific inhibition of tumor-associated carbonic anhydrases. Future Med Chem. 2023;15(1):5–7.
   PubMed Web of Science ®Google Scholar
• Aspatwar A, Tolvanen ME, Parkkila S. Phylogeny and expression of carbonic anhydrase-related proteins. BMC Mol Biol. 2010;11:25.
   PubMed Web of Science ®Google Scholar
• Tu C, Chen X, Ren X, LoGrasso PV, Jewell DA, Laipis PJ, Silverman DN. Interactions of active-site residues and catalytic activity of human carbonic anhydrase III. J Biol Chem. 1994;269(37):23002–23006.
   PubMed Web of Science ®Google Scholar
• An H, Tu C, Ren K, Laipis PJ, Silverman DN. Proton transfer within the active-site cavity of carbonic anhydrase III. Biochim Biophys Acta. 2002;1599(1-2):21–27.
   PubMed Web of Science ®Google Scholar
• Elder I, Fisher Z, Laipis PJ, Tu C, McKenna R, Silverman DN. Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase III. Proteins. 2007;68(1):337–343.
   PubMed Web of Science ®Google Scholar
• Duda DM, Tu C, Fisher SZ, An H, Yoshioka C, Govindasamy L, Laipis PJ, Agbandje-McKenna M, Silverman DN, McKenna R. Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer. Biochemistry. 2005;44(30):10046–10053.
   PubMed Web of Science ®Google Scholar
• Harju AK, Bootorabi F, Kuuslahti M, Supuran CT, Parkkila S. Carbonic anhydrase III: a neglected isozyme is stepping into the limelight. J Enzyme Inhib Med Chem. 2013;28(2):231–239.
   PubMed Web of Science ®Google Scholar
• Koester MK, Pullan LM, Noltmann EA. The p-nitrophenyl phosphatase activity of muscle carbonic anhydrase. Arch Biochem Biophys. 1981;211(2):632–642.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov. 2017;12(1):61–88.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem. 2021;13(22):1935–1937.
   PubMed Web of Science ®Google Scholar
• Kim G, Lee TH, Wetzel P, Geers C, Robinson MA, Myers TG, Owens JW, Wehr NB, Eckhaus MW, Gros G, et al. Carbonic anhydrase III is not required in the mouse for normal growth, development, and life span. Mol Cell Biol. 2004;24(22):9942–9947.
   PubMed Web of Science ®Google Scholar
• Cabiscol E, Levine RL. Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. J Biol Chem. 1995;270(24):14742–14747.
   PubMed Web of Science ®Google Scholar
• Zimmerman UJ, Wang P, Zhang X, Bogdanovich S, Forster R. Anti-oxidative response of carbonic anhydrase III in skeletal muscle. IUBMB Life. 2004;56(6):343–347.
   PubMed Web of Science ®Google Scholar
• Mallis RJ, Poland BW, Chatterjee TK, Fisher RA, Darmawan S, Honzatko RB, Thomas JA. Crystal structure of S-glutathiolated carbonic anhydrase III. FEBS Lett. 2000;482(3):237–241.
   PubMed Web of Science ®Google Scholar
• Rokutan K, Thomas JA, Sies H. Specific S-thiolation of a 30-kDa cytosolic protein from rat liver under oxidative stress. Eur J Biochem. 1989;179(1):233–239.
   PubMedGoogle Scholar
• Cabiscol E, Levine RL. The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation. Proc Natl Acad Sci U S A. 1996;93(9):4170–4174.
   PubMed Web of Science ®Google Scholar
• Ampil FL, Nathan CA, Sangster G, Caldito G. Head and neck cancer with lower neck nodal metastases: management of 23 cases and review of the literature. Oral Oncol. 2012;48(4):325–328.
   PubMed Web of Science ®Google Scholar
• Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J Clin. 2015;65(5):401–421.
   PubMed Web of Science ®Google Scholar
• Smith A, Teknos TN, Pan Q. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol. 2013;49(4):287–292.
   PubMed Web of Science ®Google Scholar
• Lo Muzio L, Pannone G, Santarelli A, Bambini F, Mascitti M, Rubini C, Testa NF, Dioguardi M, Leuci S, Bascones A, et al. Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor? Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(6):789–798.
   PubMed Web of Science ®Google Scholar
• Chien MH, Chou LS, Chung TT, Lin CH, Chou MY, Weng MS, Yang SF, Chen MK. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer. Head Neck. 2012;34(3):405–411.
   PubMed Web of Science ®Google Scholar
• Dai HY, Hong CC, Liang SC, Yan MD, Lai GM, Cheng AL, Chuang SE. Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway. Mol Carcinog. 2008;47(12):956–963.
   PubMed Web of Science ®Google Scholar
• Chu YH, Su CW, Hsieh YS, Chen PN, Lin CW, Yang SF. Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Cells. 2020;9(3):704.
   PubMed Web of Science ®Google Scholar
• Heath R, Schwartz MS, Brown IR, Carter ND. Carbonic anhydrase III in neuromuscular disorders. J Neurol Sci. 1983;59(3):383–388.
   PubMed Web of Science ®Google Scholar
• Elchuri S, Naeemuddin M, Sharpe O, Robinson WH, Huang TT. Identification of biomarkers associated with the development of hepatocellular carcinoma in CuZn superoxide dismutase deficient mice. Proteomics. 2007;7(12):2121–2129.
   PubMed Web of Science ®Google Scholar
• Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem. 2014;6(10):1149–1165.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. J Enzyme Inhib Med Chem. 2009;24(1):70–76.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg Med Chem. 2007;15(23):7229–7236.
   PubMed Web of Science ®Google Scholar
• Alzweiri M, Al-Balas Q, Al-Hiari Y. Chromatographic evaluation and QSAR optimization for benzoic acid analogues against carbonic anhydrase III. J Enzyme Inhib Med Chem. 2015;30(3):420–429.
   PubMed Web of Science ®Google Scholar
• Jarrar N, Alzweiri M, Al-Hiari Y, Farah S, A. Khanfar M. Modified hummeldreyer method and molecular modelling studies identified nicotinic acid analogues as Carbonic anhydrase III ligands. LDDD. 2016;13(5):401–410.
   Google Scholar
• Alzweiri M, Al-Hiari Y. Evaluation of vanillic acid as inhibitor of carbonic anhydrase isozyme III by using a modified Hummel-Dreyer method: approach for drug discovery. Biomed Chromatogr. 2013;27(9):1157–1161.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. J Biol Chem. 1971;246(8):2561–2573. − 
   PubMed Web of Science ®Google Scholar
• Petreni A, Bonardi A, Lomelino C, Osman SM, ALOthman ZA, Eldehna WM, El-Haggar R, McKenna R, Nocentini A, Supuran CT. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. Eur J Med Chem. 2020;190:112112.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Vullo D, Bartolucci G, Supuran CT. N-Nitrosulfonamides: A new chemotype for carbonic anhydrase inhibition. Bioorg Med Chem. 2016; 1524(16):3612–3617.
   PubMed Web of Science ®Google Scholar
• Fares M, Eldehna WM, Bua S, Lanzi C, Lucarini L, Masini E, Peat TS, Abdel-Aziz HA, Nocentini A, Keller PA, et al. Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action. J Med Chem. 2020;63(6):3317–3326.
   PubMed Web of Science ®Google Scholar
• Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, Christie CH, Dalenberg K, Di Costanzo L, Duarte JM, et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 2021;49(D1):D437–D451.
   PubMed Web of Science ®Google Scholar
• Behnke CA, Le Trong I, Godden JW, Merritt EA, Teller DC, Bajorath J, Stenkamp RE. Atomic resolution studies of carbonic anhydrase II. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 5):616–627.
   PubMedGoogle Scholar
• Schrödinger Suite Release 2022-4, Schrödinger, LLC, New York, NY, 2019. (a) Maestro v.13.4. (b) Epik, v.5.7. (c) Macromodel v.13.3. (d) Glide, v.9.2. (e) Desmond, v.6.7. (f) Prime, v.5.5. (g) Impact, v.9.2. (h) Jaguar, v.11.3.
   Google Scholar
• Banoglu E, Ercanlı T, Gür Maz T, Vullo D, Bonardi A, Gratteri P, Supuran CT. A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors. ChemMedChem. 2022;17(10):e202200056.
   PubMed Web of Science ®Google Scholar
• Ibrahim HS, Allam HA, Mahmoud WR, Bonardi A, Nocentini A, Gratteri P, Ibrahim ES, Abdel-Aziz HA, Supuran CT. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. Eur J Med Chem. 2018;152:1–9.
   PubMed Web of Science ®Google Scholar
• Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides. J Phys Chem B. 2001;105(28):6474–6487.
   Web of Science ®Google Scholar
• Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 2006;65(3):712–725.
   PubMed Web of Science ®Google Scholar
• Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, et al. OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J Chem Theory Comput. 2021;17(7):4291–4300.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–1612.
   PubMed Web of Science ®Google Scholar